Lv32
316 积分 2022-08-08 加入
肺癌患者术后肠内营养支持的探讨
3小时前
待确认
In vitro studies of the impact of maribavir on CMV-specific cellular immune responses
2天前
已完结
T Lymphocyte Reconstitution in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation: A Single Center Experience (2016-2023)
3天前
已完结
造血干细胞移植后免疫重建
4天前
已完结
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
9天前
已完结
异基因造血干细胞移植受者巨细胞病毒感染临床管理指南（2025版）
11天前
已完结
A practical guide to real-world implementation of pre-emptive therapy for Cytomegalovirus disease prevention in high-risk seronegative liver transplant recipients with seropositive donors
13天前
已完结
Expert Consensus on Cytomegalovirus Management in Recipients of CAR-T Cell and Bispecific Antibody Therapies
15天前
已完结
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study
15天前
已完结
Real-World Use of Maribavir for Refractory CMV Infection and Intolerance to Conventional Anti-CMV Agents After Allogeneic Hematopoietic Cell Transplantation
15天前
已完结
皖公网安备34019202002308
